Prospective Evaluation of the Cardiac Safety of HER2-targeted Therapies in Patients With HER2-positive Breast Cancer and Compromised Heart Function: The SAFE-HEaRt Study
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-019-05191-2
Full Text
Open PDFAbstract
Available in full text
Date
March 9, 2019
Authors
Publisher
Springer Science and Business Media LLC